Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Powderly

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
Eclinicalmedicine|November 18, 2020
Potential missed opportunities for diagnosis of cryptococcosis and the association with mortality: A cohort studyAna S Salazar, Matthew R Keller, Margaret A Olsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapyMarisa T Gerber, Kristin E Mondy, Kevin E Yarasheski, et al.
AIDS Research and Human Retroviruses|July 21, 2011
Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008Cillian F De Gascun, Allison Waters, Ciara Regan, et al.
Journal of Fungi (Basel, Switzerland)|June 2, 2021
Long-Term Mortality after <i>Histoplasma</i> Infection in People with HIVJoseph Cherabie, Patrick Mazi, Adriana M Rauseo, et al.
LGBT Health|January 12, 2018
Sex Venue-Based Network Analysis to Identify HIV Prevention Dissemination Targets for Men Who Have Sex with MenRupa R Patel, Douglas A Luke, Enola K Proctor, et al.
AIDS Research and Human Retroviruses|December 20, 2011
Human immunodeficiency virus type 1 in Ireland: phylogenetic evidence for risk group-specific subepidemicsCillian F De Gascun, Allison Waters, Ciara M Regan, et al.
Plos One|April 24, 2008
Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular riskPablo Tebas, William Keith Henry, Roy Matining, et al.
Open Forum Infectious Diseases|October 6, 2023
Leveraging CD4 Cell Count at Entry Into Care to Monitor Success of Human Immunodeficiency Virus Prevention, Treatment, and Public Health Programming in the Greater St Louis Area Between 2017 and 2020Lindsey M Filiatreau, Aaloke Mody, Daniel Vo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 7, 2004
Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdineErik J Uhlmann, Pablo Tebas, Gregory A Storch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2008
Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM studyCarl Grunfeld, David Rimland, Cynthia L Gibert, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Eclinicalmedicine|November 18, 2020
Potential missed opportunities for diagnosis of cryptococcosis and the association with mortality: A cohort studyAna S Salazar, Matthew R Keller, Margaret A Olsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapyMarisa T Gerber, Kristin E Mondy, Kevin E Yarasheski, et al.
AIDS Research and Human Retroviruses|July 21, 2011
Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008Cillian F De Gascun, Allison Waters, Ciara Regan, et al.
Journal of Fungi (Basel, Switzerland)|June 2, 2021
Long-Term Mortality after <i>Histoplasma</i> Infection in People with HIVJoseph Cherabie, Patrick Mazi, Adriana M Rauseo, et al.
LGBT Health|January 12, 2018
Sex Venue-Based Network Analysis to Identify HIV Prevention Dissemination Targets for Men Who Have Sex with MenRupa R Patel, Douglas A Luke, Enola K Proctor, et al.
AIDS Research and Human Retroviruses|December 20, 2011
Human immunodeficiency virus type 1 in Ireland: phylogenetic evidence for risk group-specific subepidemicsCillian F De Gascun, Allison Waters, Ciara M Regan, et al.
Plos One|April 24, 2008
Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular riskPablo Tebas, William Keith Henry, Roy Matining, et al.
Open Forum Infectious Diseases|October 6, 2023
Leveraging CD4 Cell Count at Entry Into Care to Monitor Success of Human Immunodeficiency Virus Prevention, Treatment, and Public Health Programming in the Greater St Louis Area Between 2017 and 2020Lindsey M Filiatreau, Aaloke Mody, Daniel Vo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 7, 2004
Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdineErik J Uhlmann, Pablo Tebas, Gregory A Storch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2008
Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM studyCarl Grunfeld, David Rimland, Cynthia L Gibert, et al.
Pageof 15